Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04326179 · ClinicalTrials.gov registry record
Targeting Infant Development With Early Screening
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 7,720
- Enrollment target
NCT04326179 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 7,720 participants.
The verdict
NCT04326179 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,720 participants
- Enrollment target
Study Summary
The purpose of this study is to assess feasibility and acceptability of parent-completed screeners of child social/emotional development, social determinants of health, and adverse childhood experiences in the setting of a pediatrics primary care clinic.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,720 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2021-08-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04326179
The ClinicalTrials.gov registry entry for NCT04326179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04326179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04326179 about?
NCT04326179 is a clinical study titled "Targeting Infant Development With Early Screening". The purpose of this study is to assess feasibility and acceptability of parent-completed screeners of child social/emotional development, social determinants of health, and adverse childhood experiences in the setting of a pediatrics primary care clinic.
What is the current status of trial NCT04326179?
This trial is currently completed. The enrollment target is 7,720 participants. The study started on 2019-11-04. Estimated completion is 2021-08-06.
Who is sponsoring clinical trial NCT04326179?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.